Balaxi Pharmaceuticals Ltd Share Price
As on 13 June 2026 at 01:11 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-17.30%
Over 6 Months
-29.62%
Over 1 Year
-57.35%
Over 3 Years
-78.29%
Balaxi Pharmaceuticals Ltd Summary
Close ₹23.24
Open ₹24
High ₹24.70
Low ₹23.10
Volume 53,516
Net Turnover (in Cr) ₹0.12
52Wk High -
52Wk Low -
52Wk High / Low
-
-
Balaxi Pharmaceuticals Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹128.30
EPS (TTM) 0.93
Book Value (BV) 24.09
Div. Yield -
P/E (TTM) 24.99
Price/Book Value 0.96
Delivery % -
Face Value 2
Key Ratios
PE Ratio 98.34
PB Ratio 2.76
EV to Sales 5.84
PEG Ratio -32.94
ROA 2.25
ROE 2.89
Debt-Equity 0.19
Net Profit Margin 5.90
Operating Profit Margin 13.08
Balaxi Pharmaceuticals Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 294.92 | 241.93 | 339.07 | 284.36 | 233.56 |
| Total Expenses | 266.25 | 201.62 | 282.15 | 229.84 | 189.23 |
| Profit Before Tax | 28.67 | 2.02 | 56.92 | 54.52 | 44.33 |
| Profit After Tax | 25.07 | -2.39 | 45.96 | 47.66 | 38.14 |
| Operating Profit After Depreciation | 31.60 | 41.99 | 57.42 | 54.66 | 44.34 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 40.98 | 40.88 | 41.41 | 28.76 | 2.45 |
| Total Non Current Assets | 67.58 | 48.17 | 46.16 | 35.47 | 5.91 |
| Total Current Assets | 242.77 | 210.17 | 193.51 | 141 | 93.77 |
| Total Assets | 310.34 | 258.34 | 239.67 | 176.47 | 99.68 |
| Total Shareholder's Fund | 231.74 | 201.36 | 182.88 | 113.16 | 64.98 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -35 | 4.87 | 6.08 | 34.14 | - |
| Net Cash Used In Investing Activities | -21.76 | -1.05 | -10.57 | -28.45 | -5.97 |
| Net Cash Used In Financing Activities | 33.88 | 30.25 | 25.51 | -0.16 | 3.65 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 66.36 | 72.59 | 114.74 | 104.04 | 88.68 |
| Total Expenses | 61.07 | 67.01 | 92.29 | 84.34 | 68.08 |
| Profit Before Tax | 5.29 | 5.58 | 22.45 | 19.70 | 20.60 |
| Profit After Tax | 3.60 | 3.65 | 16.22 | 14.67 | 15.13 |
| Operating Profit After Depreciation | 7.35 | 7.12 | 22.91 | 19.76 | 20.61 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 6.67 | 7.10 | 7.89 | 2.20 | 0.69 |
| Total Non Current Assets | 54.84 | 31.46 | 30.70 | 27.84 | 20.25 |
| Total Current Assets | 119.60 | 122.90 | 99.02 | 54.08 | 48.67 |
| Total Assets | 174.45 | 154.36 | 129.72 | 81.92 | 68.92 |
| Total Shareholder's Fund | 127.85 | 121.55 | 92.11 | 57.91 | 43.25 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -7.60 | -1.83 | -7.07 | 8.89 | 13.46 |
| Net Cash Used In Investing Activities | -24.98 | 0.46 | -2.29 | -6.87 | -20.03 |
| Net Cash Used In Financing Activities | 17.21 | 27.55 | 26.39 | -1.64 | 3.49 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 70.71 | 72.54 | 56.18 | 70.74 | 76.27 |
| Total Expenses | 70.59 | 69.45 | 55.01 | 66.60 | 63.71 |
| Profit Before Tax | 1.40 | 1.61 | 1.39 | 0.89 | 9.67 |
| Profit After Tax | 0.61 | 0.31 | 0.21 | 0.29 | 8.64 |
| Operating Profit after Depreciation | 3.04 | 3.19 | 2.76 | 2.36 | 10.87 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 20.24 | 24.59 | 19.31 | 16.71 | 9.65 |
| Total Expenses | 22.17 | 23.21 | 18.54 | 16.17 | 10.30 |
| Profit Before Tax | 0.42 | 2.12 | 4.24 | 0.26 | -1.13 |
| Profit After Tax | 0.16 | 1.53 | 3.26 | 0.19 | -1.18 |
| Operating Profit after Depreciation | 1.44 | 3 | 4.98 | 1 | -0.33 |
Balaxi Pharmaceuticals Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 22.66
S2 22.08
S3 21.06
Pivot 23.68
R1 24.26
R2 25.28
R3 25.86
Moving Average
20 SMA 24.95
50 SMA 25.03
100 SMA 23.20
200 SMA 31.08
Balaxi Pharmaceuticals Ltd Corporate Actions
Balaxi Pharmaceuticals Ltd
₹0.5/Share
Announcement Date 01 Jul 2022
Record Date 04 Jul 2022
Div Yield 5%
Balaxi Pharmaceuticals Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Balaxi Pharmaceuticals Ltd Top Mutal Funds Invested
No data available
Balaxi Pharmaceuticals Ltd News
Balaxi Pharmaceuticals to conduct AGM
On 24 August 2026
01 Jun 2026, 09:33 am
Balaxi Pharmaceuticals to hold board meeting
On 28 May 2026
11 May 2026, 10:25 am
Balaxi Pharmaceuticals to announce Quarterly Result
On 28 January 2026
22 Jan 2026, 10:34 am
Balaxi Pharmaceuticals to announce Quarterly Result
On 11 November 2025
05 Nov 2025, 04:40 pm
Balaxi Pharmaceuticals to announce Quarterly Result
On 5 August 2025
30 Jul 2025, 11:37 am
Balaxi Pharmaceuticals Ltd Stock Analysis
- Annual revenue for Balaxi Pharmaceuticals Ltd decreased by 8.59% to ₹66.36 crore in FY 2025 from ₹72.59 crore in FY 2024.
- Annual Net Profit for Balaxi Pharmaceuticals Ltd decreased by 1.34% to ₹3.60 crore in FY 2025 from ₹3.65 crore in FY 2024.
- Promoter Shareholding in Balaxi Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 65.99% in December 2025 to 65.99% in March 2026.
- Balaxi Pharmaceuticals Ltd delivered a 1-year return of -57.35% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Balaxi Pharmaceuticals Ltd share price moved up by 1.03% from its previous close of INR ₹23.24. The latest Balaxi Pharmaceuticals Ltd share price is INR ₹23.48.
- Balaxi Pharmaceuticals Ltd share price today has been at a low of 23 and a high of 23.70. Over the past 52 weeks, the Balaxi Pharmaceuticals Ltd share price has seen a low of 15.20 and a high of 56.90.
FAQ’s
What is the share price of Balaxi Pharmaceuticals Ltd today?
Balaxi Pharmaceuticals Ltd share price as on 12 Jun 2026 is ₹ 23.48
What is the Market Cap of Balaxi Pharmaceuticals Ltd?
The market cap of Balaxi Pharmaceuticals Ltd stock is ₹128.30 Cr.
What is the PE Ratio of Balaxi Pharmaceuticals Ltd?
The Price to Earnings (P/E) Ratio of Balaxi Pharmaceuticals Ltd is 98.34
What is the PB Ratio of Balaxi Pharmaceuticals Ltd?
The Price to Book (P/B) Ratio of Balaxi Pharmaceuticals Ltd is 2.76
What is the 52 week high of Balaxi Pharmaceuticals Ltd Share Price?
The 52 week high of Balaxi Pharmaceuticals Ltd share price stands at ₹-
What is the 52 week low of Balaxi Pharmaceuticals Ltd Share Price?
The 52 week low of Balaxi Pharmaceuticals Ltd share price stands at ₹-
How can I buy shares of Balaxi Pharmaceuticals Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Balaxi Pharmaceuticals Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
